Governance Choices of Genome Editing Patents

Area of Science:

• Biotechnology Law
• Intellectual Property Law
• Bioethics

Background:

• Numerous governance mechanisms exist for patent ownership and use, including government and private regimes.
• Existing scholarship has not fully explored the democratic control over these patent governance choices.
• Assessing democratic implications is vital for understanding the societal impact of emerging technologies.

Purpose of the Study:

• To analyze the democratic implications of patent governance mechanisms for genome editing technologies.
• To investigate how patent governance choices for CRISPR and similar technologies intersect with democratic control.
• To explore the concepts of democratically versus non-democratically governed patents.

Main Methods:

• Qualitative analysis of existing patent governance mechanisms.
• Examination of legal and policy frameworks surrounding intellectual property.
• Case study focus on genome editing technologies, including CRISPR.
• Conceptual analysis of democratic governance in the context of patents.

Main Results:

• Patents for controversial genome editing applications are frequently governed by non- or anti-democratic private licensing restrictions.
• While compulsory licenses engage democratic deliberation, they are currently ill-suited for specific applications.
• Current patent governance structures may not adequately reflect public interest in the distribution and limitations of genome editing technologies.

Conclusions:

• Patent governance is intrinsically linked to distributed claims of authority, impacting democratic oversight.
• Lawmakers must be vigilant as private restrictions on patents can shift rapidly.
• Further scholarly and policy attention is needed to align genome editing patent landscapes with democratic governance principles.